DMDorothea Adriana Maas

Dorothea Adriana Maas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dorothea Adriana Maas has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Gerard J. M. Martens

    Donders Centre for Neuroscience (DCN), Department of Molecular Animal Physiology, Faculty of Science, Donders Institute for Brain, Cognition and Behavior, Radboud University, 6525 GA Nijmegen, The Netherlands

    5 shared publications
  • Linda Douw

    Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Anatomy and Neurosciences, de Boelelaan 1108, Amsterdam, the Netherlands

    4 shared publications
  • Brahim Nait-Oumesmar

    Sorbonne Université, Paris Brain Institute-ICM, Inserm U1127, CNRS UMR7225, Hôpital de la Pitié-Salpêtrière, Paris, France

    3 shared publications
  • Astrid Vallès

    Department of Molecular Animal Physiology, Donders Institute for Brain, Cognition and Behavior, Centre for Neuroscience, Faculty of Science, Radboud University, Nijmegen, The Netherlands

    2 shared publications
  • Blandine Manot-Saillet

    Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, “Team: Interactions between neurons and oligodendroglia in myelination and myelin repair

    2 shared publications
  • Chloé Habermacher

    2 shared publications

Latest Publications

  • Open Access

    Experimental Framework to Investigate Glioma in Organotypic Human Cortex

    by Lotte R. Woltheus, Lucas Baudouin, Marike van Lingen, Niels Verburg, Sander Idema, Myron G. Best, Phillip de Witt Hamer, David Noske, Linda Douw, Dorien Maas

    Background: Gliomas are primary brain tumors that integrate into the surrounding brain via neuron-glioma synapses and disrupt normal neuronal functioning. Recent work links tumor-brain connectivity to clinical measures such as patients’ functional status. However, few experimental systems allow the visualization of tumor and resident brain cell architecture together in human tissue at the scale needed to connect cellular organization to clinical outcomes. To address this gap, we developed an experimental framework for investigating the neuron-glioma network in organotypic human cortex from glioma patients, designed to support future correlation of cellular architecture to clinical outcomes such as functional status and survival. Methods: Brain tissue samples containing cortex from seven glioma patients were collected during tumor resection and cultured for seven days as organotypic slices. We established several multiplexed immunohistochemistry panels to stain for glioma cells, various types of resident brain cells including neurons and cells from the oligodendrocyte lineage, as well as axonal networks and myelination patterns. Results: We demonstrated the presence of tumor cells in all samples using SOX2, a tumor cell marker. NeuN+ neuronal cells were also successfully identified, as were cells from the oligodendrocyte lineage using SOX10 (pan-lineage marker), BCAS1 (pre-myelinating oligodendrocyte marker), and ASPA (mature oligodendrocyte marker). The neuronal network and myelin were successfully visualized using MAP2 (neurons and dendrites), SMI312 (axons), and PLP1 (myelin). Conclusions: High-quality visualization of tumor cells, resident brain cells and the (myelinated) neuronal network in organotypic human cortex from glioma patients is possible after seven days of culturing. Future studies could further optimize culture conditions and should study stability of all cellular components in longer term slice cultures. Preliminary analyses indicate that cellular measures derived from human organotypic slices can be linked to patients’ functional status, demonstrating the capacity to generate data suitable for large-scale investigation of the effects of glioma-brain network architecture on clinical outcomes.

  • Myelin Matters in Schizophrenia : Neurobiological Insights from Rat Model and Human Studies

    by Dorothea Adriana Maas

    La myéline est importante dans la schizophrénie : perspectives neurobiologiques d'après un modèle chez le rat et des études chez l'humain: La schizophrénie (SZ) est un trouble psychiatrique grave dont les symptômes cognitifs découlent d'un dysfonctionnement du cortex préfrontal (CPF) et impliquent une altération de la myélinisation et des anomalies interneuronales. Dans les chapitres 1 et 2 de cette thèse, j'ai introduit l'hypothèse que la myélinisation des interneurones de la parvalbumine est affectée en SZ et que des niveaux élevés de stress oxydatif interfèrent avec la différenciation des oligodendrocytes (OLs) et entravent ainsi la myélinisation correcte. En utilisant le modèle de rat APO-SUS, au chapitre 3, j'ai montré que le comportement cognitif dépendant du PFC est altéré, qu'il y a un défaut de différenciation OL et une hypomyélinisation de l'interneuron parvalbumine dans le PFC APO-SUS, et que l'enrichissement environnemental (EE) peut rétablir la différenciation OL, la myélinisation et le comportement cognitif des rats APO-SUS. Au chapitre 4, je montre qu'il y a un stress oxydatif dans l'APO-SUS mPFC, et que celui-ci est en partie à l'origine du défaut de différenciation APO-SUS OL. Notamment, le traitement antioxydant a sauvé le stress oxydatif, la myélinisation de l'interneuron ainsi que les troubles cognitifs chez les rats APO-SUS. Les membranes de la myéline sont principalement constituées de lipides, c'est pourquoi j'ai montré au chapitre 5 que l'expression des gènes liés aux lipides dans le SZ PFC était altérée, j'ai identifié une étiologie génétique commune entre le SZ et les lipides, et montré que la performance cognitive réduite des patients SZ était en corrélation avec une teneur réduite en lipides du PFC.

  • Open Access

    Cell-autonomous mitochondrial calcium flux governs oligodendrocyte regeneration

    by Dorien A. Maas, Roxane Bancel-Vega, Lucas R. Baudouin, Philippe Bun, Blandine Manot-Saillet, Chloé Habermacher, Niels Verburg, Filippo Rusconi, Maria Cecilia Angulo

    Oligodendrocyte (OL) lineage cells drive central nervous system remyelination, yet the intrinsic mechanisms that define their regenerative potential remain unclear. We identify spontaneous, cell-autonomous intracellular Ca 2+ signaling as a critical mechanism regulating OL regeneration following demyelination. Longitudinal in vivo imaging and ex vivo recordings reveal that Ca 2+ signaling arises intrinsically within OL lineage cells after demyelination, and occurs independently from neuronal or behavioral activity. Mechanistically, mitochondrial Ca 2+ flux sustains intracellular Ca 2+ signals in oligodendroglia, and its in vivo disruption impairs oligodendrocyte precursor cell (OPC) proliferation, differentiation, and repopulation at the lesion site. Conversely, enhancing oligodendroglial Ca 2+ signaling in vivo using chemogenetics stimulates lineage expansion and differentiation. In primary human OPC cultures, modulation of mitochondrial Ca 2+ flux similarly reduces proliferation, indicating a conserved role for this pathway across species. These findings identify mitochondrial Ca 2+ flux as a central driver of the oligodendroglial regeneration and a potential therapeutic target in demyelinating diseases.

  • Open Access

    Multiscale network neuroscience in neuro-oncology: How tumors, brain networks, and behavior connect across scales

    by Dorien A Maas, Linda Douw

    Network neuroscience refers to the investigation of brain networks across different spatial and temporal scales, and has become a leading framework to understand the biology and functioning of the brain. In neuro-oncology, the study of brain networks has revealed many insights into the structure and function of cells, circuits, and the entire brain, and their association with both functional status (e.g., cognition) and survival. This review connects network findings from different scales of investigation, with the combined aim of informing neuro-oncological healthcare professionals on this exciting new field and also delineating the promising avenues for future translational and clinical research that may allow for application of network methods in neuro-oncological care.


  • Open Access

    Connecting Neurobiological Features with Interregional Dysconnectivity in Social-Cognitive Impairments of Schizophrenia

    by Florian W. Adraoui, Linda Douw, Gerard J. M. Martens, Dorien A. Maas

    Schizophrenia (SZ) is a devastating psychiatric disorder affecting about 1% of the world’s population. Social-cognitive impairments in SZ prevent positive social interactions and lead to progressive social withdrawal. The neurobiological underpinnings of social-cognitive symptoms remain poorly understood, which hinders the development of novel treatments. At the whole-brain level, an abnormal activation of social brain regions and interregional dysconnectivity within social-cognitive brain networks have been identified as major contributors to these symptoms. At the cellular and subcellular levels, an interplay between oxidative stress, neuroinflammation and N-methyl-D-aspartate receptor hypofunction is thought to underly SZ pathology. However, it is not clear how these molecular processes are linked with interregional dysconnectivity in the genesis of social-cognitive symptoms. Here, we aim to bridge the gap between macroscale (connectivity analyses) and microscale (molecular and cellular mechanistic) knowledge by proposing impaired myelination and the disinhibition of local microcircuits as possible causative biological pathways leading to dysconnectivity and abnormal activity of the social brain. Furthermore, we recommend electroencephalography as a promising translational technique that can foster pre-clinical drug development and discuss attractive drug targets for the treatment of social-cognitive symptoms in SZ.


  • Open Access

    Connecting Neurobiological Features with Interregional Dysconnectivity in Social-Cognitive Impairments of Schizophrenia

    by Florian W. Adraoui, Linda Douw, Gerard J.M. Martens, Dorien A. Maas

    Schizophrenia (SZ) is a devastating psychiatric disorder affecting about 1% of the world’spopulation. Social-cognitive impairments in SZ prevent positive social interactions and lead toprogressive social withdrawal. The neurobiological underpinnings of social-cognitive symptomsremain poorly understood, which hinders the development of novel treatments. At the wholebrainlevel, an abnormal activation of social brain regions and interregional dysconnectivity withinsocial-cognitive brain networks have been identified as major contributors to these symptoms. Atthe cellular and subcellular levels, an interplay between oxidative stress, neuroinflammation andN-methyl-D-aspartate receptor hypofunction is thought to underly SZ pathology. However, it is notclear how these molecular processes are linked with interregional dysconnectivity in the genesisof social-cognitive symptoms. Here, we aim to bridge the gap between macroscale (connectivityanalyses) and microscale (molecular and cellular mechanistic) knowledge by proposing impairedmyelination and the disinhibition of local microcircuits as possible causative biological pathwaysleading to dysconnectivity and abnormal activity of the social brain. Furthermore, we recommendelectroencephalography as a promising translational technique that can foster pre-clinical drugdevelopment and discuss attractive drug targets for the treatment of social-cognitive symptoms in SZ.


  • Open Access

    Versatile and automated workflow for the analysis of oligodendroglial calcium signals in preclinical mouse models of myelin repair

    by Dorien A. Maas, Blandine Manot-Saillet, Philippe Bun, Chloé Habermacher, Corinne Poilbout, Filippo Rusconi, Maria Cecilia Angulo

    Intracellular Ca 2+ signals of oligodendroglia, the myelin-forming cells of the central nervous system, regulate vital cellular processes including myelination. However, studies on oligodendroglia Ca 2+ signal dynamics are still scarce, especially during myelin repair, and there are no software solutions to properly analyze the unique Ca 2+ signal characteristics in these cells. Here, we provide a comprehensive experimental and analytical workflow to acquire and analyze Ca 2+ imaging data of oligodendroglia at the population and single-cell levels in preclinical mouse models of myelin repair. We report diverse ex vivo and in vivo experimental protocols to obtain reproducible Ca 2+ imaging data from oligodendroglia in demyelinated lesions. Importantly, we provide an analytical pipeline containing two free, open source and cross-platform software programs, Occam and post-prOccam, that enable the fully automated analysis of one- and two-photon Ca 2+ imaging datasets from oligodendroglia obtained by either ex vivo or in vivo Ca 2+ imaging techniques. This versatile and accessible experimental and analytical framework, which revealed significant but uncorrelated spontaneous Ca 2+ activity in oligodendroglia inside demyelinated lesions, should facilitate the elucidation of Ca 2+ -mediated mechanisms underlying remyelination and therefore help to accelerate the development of therapeutic strategies for the many myelin-related disorders, such as multiple sclerosis.

  • Open Access

    Antioxidant treatment ameliorates prefrontal hypomyelination and cognitive deficits in a rat model of schizophrenia

    by D. A. Maas, V. D. Eijsink, J. A. van Hulten, R. Panic, P. De Weerd, J. R. Homberg, A. Vallès, B. Nait-Oumesmar, G. J. M. Martens

    Cognitive dysfunction in schizophrenia (SZ) is thought to arise from neurodevelopmental abnormalities that include interneuron hypomyelination in the prefrontal cortex (PFC). Here we report that RNA-sequencing of the medial (m)PFC of the APO-SUS rat model with SZ-relevant cognitive inflexibility revealed antioxidant metabolism as the most-enriched differentially expressed pathway. Antioxidant-related gene expression was altered throughout postnatal development and preceded hypomyelination. Furthermore, reduced glutathione levels and increased mitochondria numbers were observed in the mPFC. Strikingly, chronic treatment with the glutathione precursor N-acetylcysteine (NAC) from postnatal days 5–90 restored not only antioxidant-related mRNA expression and mitochondria numbers, but also myelin-related mRNA expression and mPFC-dependent cognitive dysfunction, while blood glutathione levels remained unaffected. The promyelinating effect of NAC was at least partly due to a positive effect on oligodendrocyte lineage progression. Together, our findings highlight that oxidative stress may contribute to cognitive symptoms in the APO-SUS rat model of SZ and encourage antioxidant therapy in early phases of SZ.


  • Open Access

    Key role for lipids in cognitive symptoms of schizophrenia

    by Dorien A. Maas, Marijn B. Martens, Nikos Priovoulos, Wieteke A. Zuure, Judith R. Homberg, Brahim Nait-Oumesmar, Gerard J. M. Martens

    Schizophrenia (SZ) is a psychiatric disorder with a convoluted etiology that includes cognitive symptoms, which arise from among others a dysfunctional dorsolateral prefrontal cortex (dlPFC). In our search for the molecular underpinnings of the cognitive deficits in SZ, we here performed RNA sequencing of gray matter from the dlPFC of SZ patients and controls. We found that the differentially expressed RNAs were enriched for mRNAs involved in the Liver X Receptor/Retinoid X Receptor (LXR/RXR) lipid metabolism pathway. Components of the LXR/RXR pathway were upregulated in gray matter but not in white matter of SZ dlPFC. Intriguingly, an analysis for shared genetic etiology, using two SZ genome-wide association studies (GWASs) and GWAS data for 514 metabolites, revealed genetic overlap between SZ and acylcarnitines, VLDL lipids, and fatty acid metabolites, which are all linked to the LXR/RXR signaling pathway. Furthermore, analysis of structural T1-weighted magnetic resonance imaging in combination with cognitive behavioral data showed that the lipid content of dlPFC gray matter is lower in SZ patients than in controls and correlates with a tendency towards reduced accuracy in the dlPFC-dependent task-switching test. We conclude that aberrations in LXR/RXR-regulated lipid metabolism lead to a decreased lipid content in SZ dlPFC that correlates with reduced cognitive performance.


  • Open Access

    Interneuron hypomyelination is associated with cognitive inflexibility in a rat model of schizophrenia

    by Dorien A. Maas, Vivian D. Eijsink, Marcia Spoelder, Josephus A. van Hulten, Peter De Weerd, Judith R. Homberg, Astrid Vallès, Brahim Nait-Oumesmar, Gerard J. M. Martens

    Impaired cognitive functioning is a core feature of schizophrenia, and is hypothesized to be due to myelination as well as interneuron defects during adolescent prefrontal cortex (PFC) development. Here we report that in the apomorphine-susceptible (APO-SUS) rat model, which has schizophrenia-like features, a myelination defect occurred specifically in parvalbumin interneurons. The adult rats displayed medial PFC (mPFC)-dependent cognitive inflexibility, and a reduced number of mature oligodendrocytes and myelinated parvalbumin inhibitory axons in the mPFC. In the developing mPFC, we observed decreased myelin-related gene expression that persisted into adulthood. Environmental enrichment applied during adolescence restored parvalbumin interneuron hypomyelination as well as cognitive inflexibility. Collectively, these findings highlight that impairment of parvalbumin interneuron myelination is related to schizophrenia-relevant cognitive deficits.